Sam68通过调控Hedgehog/Gli信号通路介导口腔鳞癌顺铂耐药的分子机制研究
批准号:
81802713
项目类别:
青年科学基金项目
资助金额:
21.0 万元
负责人:
陈树伟
依托单位:
学科分类:
H1821.肿瘤治疗抵抗
结题年份:
2021
批准年份:
2018
项目状态:
已结题
项目参与者:
周冠群、罗春玲、林晓平、李欢、彭弯、苏旋、付晓燕、陈志鹏、李思昊
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
复发性和/或转移性口腔鳞癌患者对顺铂耐药后预后极差,逆转顺铂耐药是提高患者生存率的关键。Hedgehog (Hh)/Gli通路与肿瘤干细胞干性和耐药密切相关,但其调控机制仍不明确。我们的前期研究发现:Sam68高表达促进口腔鳞癌进展和顺铂耐药;过表达Sam68上调Hh/Gli通路和干细胞相关转录因子表达;抑制Hh/Gli通路下调干细胞相关转录因子表达。据此我们提出假说:Sam68通过调控Hh/Gli通路维持口腔鳞癌干细胞干性促进顺铂耐药。本项目拟通过体内外实验,探讨Sam68通过调控Hh/Gli通路促进口腔鳞癌顺铂耐药的机制,明确Hh/Gli通路维持口腔鳞癌干细胞干性促进顺铂耐药的分子机制,并在口腔鳞癌组织样本中验证假说内容,明确Sam68/Hh/Gli通路的临床意义。本项目将揭示口腔鳞癌顺铂耐药的新机制,为确立Sam68/Hh/Gli通路作为逆转口腔鳞癌顺铂耐药的新靶点提供科学依据。
英文摘要
Cisplatin resistance poses a major challenge to patients with recurrent and/or metastatic (R/M) oral cavity squamous cell carcinoma, which leads to an extremely poor prognosis. Reversal of cisplatin resistance is crucial in improving survival of patients with R/M oral cavity squamous cell carcinoma. Hedgehog/Gli signaling pathway correlates with cancer stem cell maintenance and chemoresistance, whereas the molecular mechanism beneath is unclear. Sam68 is a multifunctional RNA binding protein, which regulates RNA alternative splicing and RNA 3’-end formation. It plays pivotal roles in cell cycle regulation, promoting tumorigenesis and progression in a variety of malignancies. Our previous study showed that the expression of Sam68 was upregulated in oral cavity squamous cell carcinoma, which was positively correlated with N classification and recurrence (P = 0.026, and 0.002, respectively), and also significantly associated with poor overall and disease-free survival rate (P = 0.009, and 0.002, respectively). Furthermore, overexpression of Sam68 significantly inhibited cisplatin-induced apoptosis in vitro and in vivo (published on J Exp Clin Cancer Res in 2016, IF = 5.189), while the molecular mechanism beneath was still unclear. Recently, Signal Transduction 45-Pathway Reporter Array performed on Sam68-overexpressed SCC-9 and SCC-25 cell lines indicated that cell apoptosis associated pathways were activated with top fold changes, including Hedgehog/Gli, Nanog/Nanog, and Notch/RBP-Jk signaling pathways. Overexpression of Sam68 upregulated the expression of signaling molecules of Hedgehog/Gli signaling pathway and stem cell associated transcription factors. Inhibition of Hedgehog/Gli signaling pathway downregulated stem cell associated transcription factors. In this study, we plan to investigate the functions and mechanisms of Sam68 in promoting stem cell maintenance and cisplatin resistance through regulation of Hedgehog/Gli signaling pathway in oral cavity squamous cell carcinoma both in vitro and in vivo. Finally, we will validate the above hypothesis in clinical specimen from patients with oral cavity squamous cell carcinoma and illuminate the role and clinical value of Sam68/Hh/Gli signaling pathway. Through this study, we will provide a novel mechanism of cisplatin resistance and potential novel targets for reversal of cisplatin resistance in patients with oral cavity squamous cell carcinoma.
复发性和/或转移性口腔鳞癌患者对顺铂耐药后预后极差,逆转顺铂耐药是提高患者生存率的关键。Hedgehog (Hh)/Gli通路与肿瘤干细胞干性和耐药密切相关,但其调控机制仍不明确。我们的前期研究发现:Sam68高表达促进口腔鳞癌进展和顺铂耐药;过表达Sam68上调Hh/Gli通路和干细胞相关转录因子表达;抑制Hh/Gli通路下调干细胞相关转录因子表达。据此我们提出假说:Sam68通过调控Hh/Gli通路维持口腔鳞癌干细胞干性促进顺铂耐药。本项目拟通过体内外实验,探讨Sam68通过调控Hh/Gli通路促进口腔鳞癌顺铂耐药的机制,明确Hh/Gli通路维持口腔鳞癌干细胞干性促进顺铂耐药的分子机制,并在口腔鳞癌组织样本中验证假说内容,明确Sam68/Hh/Gli通路的临床意义。本项目将揭示口腔鳞癌顺铂耐药的新机制,为确立Sam68/Hh/Gli通路作为逆转口腔鳞癌顺铂耐药的新靶点提供科学依据。.本课题围绕Sam68在口腔鳞癌中的作用及机制展开研究。研究期间我们发现Sam68在OSCC组织及细胞系中表达升高。同时,通过构建OSCC组织芯片,我们研究结果发现Sam68免疫组化评分在肿瘤组织中显著高于癌旁组织。Sam68在OSCC中高表达,但其在OSCC恶性进程中的作用机制尚未明确。我们成功敲降了两株OSCC细胞系的Sam68表达。流式细胞技术与EdU细胞增殖实验提示,敲降Sam68能显著抑制OSCC细胞增殖能力。对此,我们通过二代测序显示敲降Sam68可显著抑制了Wnt信号通路,为后面探索靶向Sam68抑制OSCC细胞增殖的研究提供了证据与思路。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Older age is a risk factor associated with poor prognosis of patients with squamous cell carcinoma of the oral cavity
年龄较大是口腔鳞状细胞癌患者预后不良的危险因素
DOI:10.1007/s00405-020-05963-3
发表时间:2020-04-22
期刊:EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
影响因子:2.6
作者:Chen,Shuwei;Lin,Zhu;Song,Ming
通讯作者:Song,Ming
Transcervical dissection of metastatic suprahyoid retropharyngeal lymph nodes from papillary thyroid carcinoma through three anatomical barriers
通过三个解剖屏障对甲状腺乳头状癌转移性舌骨上咽后淋巴结进行宫颈清扫术
DOI:10.1016/j.ijom.2020.06.022
发表时间:2021
期刊:International Journal of Oral and Maxillofacial Surgery
影响因子:2.4
作者:S. Chen;H. Yang;X. Su;A. Yang;W. Liu
通讯作者:W. Liu
Forkhead box D1 promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma
Forkhead box D1 通过上调口腔鳞状细胞癌中的 lncRNA CYTOR 促进 EMT 和化疗耐药
DOI:10.1016/j.canlet.2020.11.046
发表时间:2021-01-23
期刊:CANCER LETTERS
影响因子:9.7
作者:Chen, Shuwei;Yang, Muwen;Zhang, Quan
通讯作者:Zhang, Quan
High SOX8 expression promotes tumor growth and predicts poor prognosis through GOLPH3 signaling in tongue squamous cell carcinoma
SOX8 高表达通过 GOLPH3 信号传导促进舌鳞状细胞癌肿瘤生长并预测不良预后
DOI:10.1002/cam4.3041
发表时间:2020-04-19
期刊:CANCER MEDICINE
影响因子:4
作者:Chen, Shuwei;Li, Huan;Song, Ming
通讯作者:Song, Ming
Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation
长非编码RNA FOXD2-AS1通过STAT3激活增强喉鳞状细胞癌的化疗耐药性
DOI:10.1038/s41419-020-2232-7
发表时间:2020-01-20
期刊:CELL DEATH & DISEASE
影响因子:9
作者:Li, Rui;Chen, Shuwei;Zhang, Siyi
通讯作者:Zhang, Siyi
CMTM6调控口腔鳞癌免疫微环境的机制研究
- 批准号:--
- 项目类别:省市级项目
- 资助金额:15.0万元
- 批准年份:2024
- 负责人:陈树伟
- 依托单位:
国内基金
海外基金















{{item.name}}会员


